Status:
COMPLETED
Glycaemic Control and Quality of Care in Type 2 Diabetes on NovoMix® 30 Previously Treated With Mixtard® Insulins
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Diabetes
Diabetes Mellitus, Type 2
Eligibility:
All Genders
18+ years
Brief Summary
This observational study is conducted in Europe. The objective of this retrospective observational cohort analysis is to assess the changes of glycaemic control and quality of care in those Type 2 dia...
Eligibility Criteria
Inclusion
- Subjects diagnosed with type 2 diabetes previously treated with BHI for at least 12 months
- Analogue premix administration for the last 6 months
Exclusion
- Known or suspected allergy to insulin aspart
- Newly diagnosed diabetes
Key Trial Info
Start Date :
October 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2008
Estimated Enrollment :
3495 Patients enrolled
Trial Details
Trial ID
NCT00657319
Start Date
October 1 2007
End Date
April 1 2008
Last Update
January 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Budapest, Hungary, 1025